Quantum BioPharma Ltd. is trading at $3.53 (7.1% down) in pre-market, extending recent volatility. - This downward trend follows the FDA's clinical hold on its Lucid-MS IND application announced earlier in June. - The stock has experienced several sharp daily moves and significant volatility since the announcement, with no new overnight company-specific news evident for today's further decline. - Broader market indices are trading roughly flat in futures, suggesting the decline is largely decoupled from general market sentiment.